MemHsp70 Receptor-mediated Multifunctional Ordered Mesoporous Carbon Nanospheres for Photoacoustic Imaging-Guided Synergistic Targeting Trimodal Therapy
Source abstract
Abstract
Integrating multiple discrete function-related theranostic modalities into one platform for effective cancer treatments has been considered to be a challenge for current nanomedicine design. In this work, a "four-in-one" theranostic system was simply prepared and developed for photoacoustic (PA) imaging-guided synergistic targeting chemo-gene-thermo trimodal therapy of breast cancer. In this system, polyethylene glycol (PEG)-bridged polyethylenimine (PEI) and a memHsp70 receptor-targeting peptide (TKD), PPT, was uniformly capped on doxorubicin (DOX)-loaded oxidized mesoporous carbon nanospheres (OMCN) to encapsulate therapeutic genes into cancer cells via active targeting accumulation. Taking both the advantages of OMCN (high photothermal conversion, strong PA contrast, and controllable drug loading) and the hydrophilic polymer (gene vector, switchable pores' cap, and targeting ability), the "four-in-one" theranostic system exhibited distinct PA imaging visualization, NIR/pH sensitive drug/gene release, and synergistic targeting therapeutic outcome, which were much superior than the single therapy or the combination of two treatments.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photoacoustic and Ultrasonic Imaging · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Pharmaceutics, School of Pharmacy, Key Laboratory of Smart Drug Delivery, Ministry of Education, Fudan University, Shanghai 201203, China
Center for Advanced Low-dimension Materials, Donghua University, Shanghai 201620, China
Center of Analysis and Measurement, Fudan University, Shanghai 200433, China
Funding
Ministry of Science and Technology of the People's Republic of China · Deutsche Forschungsgemeinschaft · National Natural Science Foundation of China
References (35)
Show source-provided references
1. 10.1002/smll.20120215510.1002/smll.201202155 ↗
2. 10.1021/nn400334y10.1021/nn400334y ↗
3. 10.1021/nn406425h10.1021/nn406425h ↗
4. 10.1021/nn900215k10.1021/nn900215k ↗
5. 10.1039/C4CS00011K10.1039/C4CS00011K ↗
6. 10.1016/j.addr.2015.12.01810.1016/j.addr.2015.12.018 ↗
7. 10.1021/acs.chemrev.5b0014810.1021/acs.chemrev.5b00148 ↗
8. 10.1038/nature1581810.1038/nature15818 ↗
9. 10.1039/C2CS35342C10.1039/C2CS35342C ↗
10. 10.1039/C5CS00798D10.1039/C5CS00798D ↗
11. 10.1002/smll.20160027110.1002/smll.201600271 ↗
12. 10.1021/acsami.5b0190310.1021/acsami.5b01903 ↗
13. 10.1039/C2CS15261D10.1039/C2CS15261D ↗
14. 10.1002/adfm.20140399110.1002/adfm.201403991 ↗
15. 10.1016/j.biomaterials.2015.10.04810.1016/j.biomaterials.2015.10.048 ↗
16. 10.1002/smll.20160063510.1002/smll.201600635 ↗
17. 10.1016/j.addr.2011.02.00210.1016/j.addr.2011.02.002 ↗
18. 10.1002/anie.20130762810.1002/anie.201307628 ↗
19. 10.1038/srep3924510.1038/srep39245 ↗
20. 10.1016/j.ijpharm.2015.12.01310.1016/j.ijpharm.2015.12.013 ↗
21. 10.1073/pnas.101606510810.1073/pnas.1016065108 ↗
22. 10.4049/jimmunol.172.2.97210.4049/jimmunol.172.2.972 ↗
23. 10.1016/j.biomaterials.2016.05.03310.1016/j.biomaterials.2016.05.033 ↗
24. 10.1039/C4RA03993A10.1039/C4RA03993A ↗
25. 10.1021/ja991795g10.1021/ja991795g ↗
26. 10.1002/jgm.17310.1002/jgm.173 ↗
27. 10.1016/j.actbio.2016.02.02110.1016/j.actbio.2016.02.021 ↗
28. 10.1021/ja201017510.1021/ja2010175 ↗
29. 10.2147/IJN.S10302010.2147/IJN.S103020 ↗
30. 10.1002/anie.20090261210.1002/anie.200902612 ↗
31. 10.1021/nn202073m10.1021/nn202073m ↗
32. 10.1021/nn900918w10.1021/nn900918w ↗
33. 10.1002/adma.20130449710.1002/adma.201304497 ↗
34. 10.1038/ncomms1122110.1038/ncomms11221 ↗
35. 10.1021/acsnano.6b0323810.1021/acsnano.6b03238 ↗